Header Logo

Connection

ROBERT ATMAR to Norovirus

Back to Details
This is a "connection" page, showing publications ROBERT ATMAR has written about Norovirus.
ROBERT ATMAR
Connection Strength
15.124
Norovirus
  1. Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Dec 16; 230(6):1376-1379.
    View in: PubMed
    Score: 0.693
  2. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.665
  3. Birth Cohort Studies: Toward Understanding Protective Immunity to Human Noroviruses. Clin Infect Dis. 2021 01 27; 72(2):230-232.
    View in: PubMed
    Score: 0.529
  4. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection. J Infect Dis. 2020 02 18; 221(5):739-743.
    View in: PubMed
    Score: 0.496
  5. Norovirus in health care and implications for the immunocompromised host. Curr Opin Infect Dis. 2019 08; 32(4):348-355.
    View in: PubMed
    Score: 0.477
  6. Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. J Infect Dis. 2019 07 19; 220(4):603-614.
    View in: PubMed
    Score: 0.476
  7. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7).
    View in: PubMed
    Score: 0.475
  8. An Exploratory Study of the Salivary Immunoglobulin A Responses to 1 Dose of a Norovirus Virus-Like Particle Candidate Vaccine in Healthy Adults. J Infect Dis. 2019 01 09; 219(3):410-414.
    View in: PubMed
    Score: 0.459
  9. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.450
  10. Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther. 2017 Aug; 39(8):1537-1549.
    View in: PubMed
    Score: 0.415
  11. Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial. J Infect Dis. 2016 Sep 15; 214(6):845-53.
    View in: PubMed
    Score: 0.385
  12. Antiviral targets of human noroviruses. Curr Opin Virol. 2016 06; 18:117-25.
    View in: PubMed
    Score: 0.384
  13. Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clin Vaccine Immunol. 2016 02; 23(2):181-3.
    View in: PubMed
    Score: 0.371
  14. Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies. J Clin Microbiol. 2015 Dec; 53(12):3916-8.
    View in: PubMed
    Score: 0.366
  15. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015 Aug; 22(8):923-9.
    View in: PubMed
    Score: 0.358
  16. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011 Dec 08; 365(23):2178-87.
    View in: PubMed
    Score: 0.281
  17. Transmission of viruses through shellfish: when specific ligands come into play. Curr Opin Virol. 2012 Feb; 2(1):103-10.
    View in: PubMed
    Score: 0.280
  18. Noroviruses everywhere: has something changed? Curr Opin Infect Dis. 2006 Oct; 19(5):467-74.
    View in: PubMed
    Score: 0.196
  19. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006 Jun; 35(2):275-90, viii.
    View in: PubMed
    Score: 0.192
  20. Overcoming host restrictions to enable continuous passaging of GII.3 human norovirus in human intestinal enteroids. Sci Adv. 2026 Feb 06; 12(6):eaeb0455.
    View in: PubMed
    Score: 0.187
  21. Mutational analysis of human norovirus VP2 elucidates critical molecular interactions for virus assembly. J Virol. 2026 02 17; 100(2):e0142025.
    View in: PubMed
    Score: 0.186
  22. Functional diversity in GII.4 norovirus entry: HBGA binding and capsid clustering dynamics. Proc Natl Acad Sci U S A. 2025 Oct 07; 122(40):e2517493122.
    View in: PubMed
    Score: 0.183
  23. Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
    View in: PubMed
    Score: 0.180
  24. Norovirus replication, host interactions and vaccine advances. Nat Rev Microbiol. 2025 Jun; 23(6):385-401.
    View in: PubMed
    Score: 0.174
  25. 2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 02 25; 99(2):e0093824.
    View in: PubMed
    Score: 0.174
  26. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 11 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.171
  27. Re: Nosocomial outbreak of norovirus gastroenteritis and investigation of ABO histo-blood group type in infected staff and patients. J Hosp Infect. 2004 Oct; 58(2):163-4.
    View in: PubMed
    Score: 0.171
  28. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. J Virol. 2024 07 23; 98(7):e0202023.
    View in: PubMed
    Score: 0.167
  29. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat Commun. 2023 10 16; 14(1):6516.
    View in: PubMed
    Score: 0.160
  30. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.159
  31. Effect of Norovirus Inoculum Dose on Virus Kinetics, Shedding, and Symptoms. Emerg Infect Dis. 2023 07; 29(7):1349-1356.
    View in: PubMed
    Score: 0.156
  32. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 02 28; 14(1):1148.
    View in: PubMed
    Score: 0.153
  33. Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in Seawater. Emerg Infect Dis. 2022 07; 28(7):1475-1479.
    View in: PubMed
    Score: 0.146
  34. Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses. mBio. 2022 04 26; 13(2):e0284821.
    View in: PubMed
    Score: 0.143
  35. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat Commun. 2022 03 10; 13(1):1241.
    View in: PubMed
    Score: 0.143
  36. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.139
  37. Bile Goes Viral. Viruses. 2021 05 27; 13(6).
    View in: PubMed
    Score: 0.135
  38. New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids. mSphere. 2021 01 27; 6(1).
    View in: PubMed
    Score: 0.132
  39. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing. J Virol. 2020 12 09; 95(1).
    View in: PubMed
    Score: 0.131
  40. Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection. J Biol Chem. 2020 11 20; 295(47):15974-15987.
    View in: PubMed
    Score: 0.129
  41. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23782-23793.
    View in: PubMed
    Score: 0.129
  42. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 01 21; 117(3):1700-1710.
    View in: PubMed
    Score: 0.123
  43. Human Norovirus Histo-Blood Group Antigen (HBGA) Binding Sites Mediate the Virus Specific Interactions with Lettuce Carbohydrates. Viruses. 2019 Sep 08; 11(9).
    View in: PubMed
    Score: 0.120
  44. Human Monoclonal Antibodies That Neutralize Pandemic GII.4?Noroviruses. Gastroenterology. 2018 12; 155(6):1898-1907.
    View in: PubMed
    Score: 0.112
  45. Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation. Emerg Infect Dis. 2018 08; 24(8):1453-1464.
    View in: PubMed
    Score: 0.111
  46. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades. J Virol. 2017 07 15; 91(14).
    View in: PubMed
    Score: 0.103
  47. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.102
  48. Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One. 2017; 12(1):e0170162.
    View in: PubMed
    Score: 0.100
  49. Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel. 2017 Feb; 30(2):129-139.
    View in: PubMed
    Score: 0.100
  50. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A. 2016 10 04; 113(40):E5830-E5837.
    View in: PubMed
    Score: 0.098
  51. Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol. 2016 10 01; 90(19):8906-23.
    View in: PubMed
    Score: 0.098
  52. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.097
  53. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol. 2016 09; 97(9):2291-2300.
    View in: PubMed
    Score: 0.097
  54. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.095
  55. Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay. PLoS One. 2015; 10(5):e0126571.
    View in: PubMed
    Score: 0.089
  56. Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant. 2015 Jul; 15(7):1874-81.
    View in: PubMed
    Score: 0.088
  57. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):168-77.
    View in: PubMed
    Score: 0.086
  58. Characterization of cross-reactive norovirus-specific monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):160-7.
    View in: PubMed
    Score: 0.086
  59. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine. Vaccine. 2015 Jan 15; 33(4):568-76.
    View in: PubMed
    Score: 0.086
  60. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015 Mar 15; 211(6):870-8.
    View in: PubMed
    Score: 0.085
  61. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A. 2014 Sep 23; 111(38):E4043-52.
    View in: PubMed
    Score: 0.085
  62. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.084
  63. A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis. 2014 Dec 01; 210(11):1763-71.
    View in: PubMed
    Score: 0.084
  64. Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel. 2014 Oct; 27(10):339-49.
    View in: PubMed
    Score: 0.084
  65. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J Virol. 2014 Jun; 88(11):6168-80.
    View in: PubMed
    Score: 0.082
  66. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.081
  67. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.081
  68. Environmental detection of genogroup I, II, and IV noroviruses by using a generic real-time reverse transcription-PCR assay. Appl Environ Microbiol. 2013 Nov; 79(21):6585-92.
    View in: PubMed
    Score: 0.079
  69. Norovirus contamination on French marketed oysters. Int J Food Microbiol. 2013 Sep 02; 166(2):244-8.
    View in: PubMed
    Score: 0.079
  70. Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol. 2013 Jun; 51(6):1803-8.
    View in: PubMed
    Score: 0.077
  71. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis. 2013 Mar; 19(3):431-8.
    View in: PubMed
    Score: 0.076
  72. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol. 2011 Sep; 85(17):8635-45.
    View in: PubMed
    Score: 0.068
  73. Strain-dependent norovirus bioaccumulation in oysters. Appl Environ Microbiol. 2011 May; 77(10):3189-96.
    View in: PubMed
    Score: 0.067
  74. Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis. 2010 Jul 15; 51(2):123-30.
    View in: PubMed
    Score: 0.064
  75. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med. 2010 Jul; 10(50):61-70.
    View in: PubMed
    Score: 0.064
  76. Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol. 2010 Aug; 76(16):5621-30.
    View in: PubMed
    Score: 0.063
  77. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010 May; 48(5):1673-6.
    View in: PubMed
    Score: 0.062
  78. Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer. J Clin Microbiol. 2010 Mar; 48(3):915-20.
    View in: PubMed
    Score: 0.061
  79. Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect. 2009 Jun; 72(2):185-7.
    View in: PubMed
    Score: 0.058
  80. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis. 2009 Apr 01; 48(7):e75-7.
    View in: PubMed
    Score: 0.058
  81. Detection and quantification of noroviruses in shellfish. Appl Environ Microbiol. 2009 Feb; 75(3):618-24.
    View in: PubMed
    Score: 0.057
  82. Aichi virus, norovirus, astrovirus, enterovirus, and rotavirus involved in clinical cases from a French oyster-related gastroenteritis outbreak. J Clin Microbiol. 2008 Dec; 46(12):4011-7.
    View in: PubMed
    Score: 0.056
  83. Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis. 2007 Apr 15; 44(8):1032-9.
    View in: PubMed
    Score: 0.050
  84. Real-time RT-PCR for norovirus screening in shellfish. J Virol Methods. 2005 Jan; 123(1):1-7.
    View in: PubMed
    Score: 0.043
  85. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 2004 Jun; 12(6):279-87.
    View in: PubMed
    Score: 0.042
  86. Laboratory efforts to cultivate noroviruses. J Gen Virol. 2004 Jan; 85(Pt 1):79-87.
    View in: PubMed
    Score: 0.041
  87. A semiquantitative approach to estimate Norwalk-like virus contamination of oysters implicated in an outbreak. Int J Food Microbiol. 2003 Oct 15; 87(1-2):107-12.
    View in: PubMed
    Score: 0.040
  88. Glycan Recognition in Human Norovirus Infections. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.035
  89. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.